Eyenovia and Formosa partner for new ophthalmic therapeutics
Pharmaceutical Technology
FEBRUARY 16, 2023
The collaboration will combine the Optejet dispensing technology of Eyenovia with the APNT nanoparticle formulation platform of Formosa to develop topical therapeutics. The Optejet microdose formulation and delivery platform use Microdose Array Print (MAP) technology for delivering 6ml-8ml of the drug.
Let's personalize your content